opportunity in the indian cardiovascular pharmaceuticals market_feedback ots_2015
DESCRIPTION
Market Research, India Market Size, India Market Opportunity, Market Forecast, Market GrowthTRANSCRIPT
-
Feedback Business Consulting Services Pvt. Ltd. www.feedbackconsulting.com
Market Research
Customer Experience
Strategic Business Advisory
Implementation Assistance
2015
-
2 |
Base Year: April 2013 to 2014 (FY 14)
Market Forecast: FY 14 to FY 19
Currency: Rs.
The market has been classified as below
Anti Hypertensive
ACE Inhibitors
Beta Blockers
Calcium Channel Blockers
Product Categorization
North
South
East
West
Regional Classification
-
3 |
Section 1: Background
Scope of this research
Research aim and objectives
Research methodology
Section 2: Executive Summary
Market landscape
Future opportunity
Section 3: Market Overview
Market value chain
Market structure
Players presence
Key market trends
Distribution structure
Section 4: Estimate of Market Size in India
All India market size (Value)
Past 3 years market growth
Section 1 to 4
-
4 |
Section 5: Market Share Estimates
Market size by players
Market size by product categories
Market size by regions
Section 6: Factors Impacting Market Growth
Market drivers
Market challenges
Market restraints
Section 7: Market Forecast
Overall market forecast FY 14 to FY 19
Section 8: Snapshot of Top 3 Players
Section 9: About Feedback Consulting
Section 5 to 9
-
5 |
List of Charts
1. Market value chain 2. Market structure 3. Players presence 4. Distribution structure
5. All India market size (Value) 6. Past 3 years market growth 7. Market size by players 8. Market size by product categories 9. Market size by regions 10. Overall market forecast FY 14 to FY 19
List of Players Covered
AstraZeneca Pharma India Limited Aventis Pharma Limited Cipla Limited Dr. Reddys Laboratories Limited GlaxoSmithKline Pharmaceuticals Limited Lupin Limited
Merck Limited Novartis India Limited Pfizer Limited Ranbaxy Laboratories Limited Sun Pharmaceutical Industries Limited Torrent Pharmaceuticals Limited
BristolMyers Squibb India Private Limited Cadila Pharmaceuticals Limited Intas Pharmaceuticals Limited USV Limited
-
6 |
100% payment in advance
The report will be delivered in 10 working days from the day of placing order
No of pages: 50 (approx.)
-
7 |
This report provides an insight into the Indian Cardiovascular Pharmaceuticals current market scenario, structure and practices.
In depth market scenario includes;
Current market size estimate
Market size by players Top Companies
Market size by product categories Anti Hypertensives, ACE Inhibitors, Beta Blockers and Calcium Channel Blockers
Market size by regions North, South, East, West
Market structure details the value chain key players presence across products. Market practices include understanding the Cardiovascular Pharmaceuticals market sets business, market trends, and distribution practices.
The report also provides a snapshot of key competition, past market trends with forecast over the next 5 years, anticipated growth rates and the principal factors driving and impacting growth.
Market data and analytics are derived from a combination of primary and secondary sources.
-
8 |
All Rights Reserved
No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic,
mechanical, photocopying, recording or otherwise, without the prior permission of the publisher, Feedback Business Consulting Services Pvt. Limited. The information contained herein has been obtained from sources believed to be reliable. Feedback Business Consulting disclaims all warranties as to the accuracy, completeness or adequacy of such information. Feedback Business Consulting shall have no liability for errors, omissions or inadequacies in the information contained herein, or for interpretations thereof
For information regarding permission, write to / reach us at:
Feedback Business Consulting Services Private Limited,
5th floor, Oxford Towers, 139, Airport Road,
Bangalore 560 008 | India
Phone: +91 80 4062 3800 / 91 80 4062 3801
E-mail: [email protected]